01 8Velcade
02 7Velcade
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 408
2019 Revenue in Millions : 751
Growth (%) : -46
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 1,100
2018 Revenue in Millions : 1,206
Growth (%) : -9
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 981
2019 Revenue in Millions : 1,123
Growth (%) : -13
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 925
2020 Revenue in Millions : 941
Growth (%) : 6
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 388
2021 Revenue in Millions : 925
Growth (%) : -58
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 48
2022 Revenue in Millions : 388
Growth (%) : -86
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : -2.50%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 1,618
2014 Revenue in Millions : 1,333
Growth (%) : -18%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 1,224
2015 Revenue in Millions : 1,333
Growth (%) : -8
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 1,114
2016 Revenue in Millions : 1,224
Growth (%) : -9
LOOKING FOR A SUPPLIER?